In sync with its strategy to expand in the medical sector, Avery Dennison Corporation (NYSE:AVY) has acquired Longford, Ireland-based Finesse Medical, a maker of materials used for wound care and skin treatments.
Finesse Medical specializes in the development and application of advanced technologies in wound care and skin treatment. This includes skin barrier films and protection creams, and silicone and polyurethane foam wound dressings. It is a key supplier to global healthcare-product original equipment manufacturers and also provides contract manufacturing and product development services. The company generated revenues of around $17 million last year.
Finesse Medical is a strategic fit with Avery Dennison’s Vancive Medical Technologies. Vancive Medical Technologies was previously reported as a standalone segment but now comes under the Industrial and Healthcare Materials segment which generated 7% of Avery Dennison’s revenues in the first quarter of 2017. Finesse Medical’s product portfolio of silicone gels and polyurethane foam dressings will complement Avery Dennison’s products in wound care. Further, its converting and packaging capabilities will enable Avery Dennison to offer expanded manufacturing services to customers.
Avery Dennison Corporation Price
AGCO Corporation (AGCO): Free Stock Analysis Report
Parker-Hannifin Corporation (PH): Free Stock Analysis Report
Altra Industrial Motion Corp. (AIMC): Free Stock Analysis Report
Avery Dennison Corporation (AVY): Free Stock Analysis Report
Original post